Statistics

Total Visits

Views
A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)104

Select a period of time:

Number of views in the range

Views
A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)27

Views

Views
November 20257
December 20252
January 20260
February 20261
March 20266
April 20262
May 20269
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil3
Argentina3
Colombia2
Canada1
Chile1
Algeria1
Ecuador1
France1
United Kingdom1
 

Top cities views

Views
Ashburn3
Adana1
Almada1
Alvorada do Norte1
Annaba1
Bogotá1
Canning1
Chennai1
Corpus Christi1
González Catán1